Skip to main content
. 2010 Sep 17;11:212. doi: 10.1186/1471-2474-11-212

Table 4.

Significance of treatment preference before randomisation on LBP and activity limitation

They preferred..
They got ....
.. educational
.. educational
.. training
.. educational
.. educational
.. training
.. training
.. training
LBP n/median (IQR) n/median (IQR) n/median (IQR) n/median (IQR)

Baseline 4 6.5 (6-7) 23 6 (5-7) 4(1) 7.5 (7-9) 19(1) 6 (5-7)
2 months 3(1) 3 (2-6) 22(1) 3 (2-6) 5 4 (3-7) 18(2) 5 (2-6)
6 - 3(1) 5 (3-6) 18(5) 4 (3-4) 5 6 (4-7) 18(2) 5 (3-6)
12 -. 3(1) 6 (3-7) 19(4) 4 (1-6) 4(1) 6.5 (6-8.5) 16(4) 5 (3-5)

Activity limitation

Baseline 4 17 (15-19) 23 13 (10-15) 5 14 (6-19) 20 13 (11-16)
2 months 3(1) 13 (12-16) 22(1) 7.5 (6-15) 5 13 (9-18) 19(1) 12 (6-16)
6 - 3(1) 16 (11-16) 18(5) 10 (6-12) 5 10 (8-18) 18(2) 14 (7-16)
12 - 3(1) 16(15-18) 19(4) 10 (3-12) 4(1) 12 (11-20) 16(4) 11 (9-17)

For those 52 having indicated a treatment preference before randomisation, the numbers in each of the four possible combinations (columns) are presented to the left, with those who did not respond given in brackets where relevant. LBP and activity limitation are given as medians (and IQRs).

HHS Vulnerability Disclosure